APA (7th ed.) Citation

L, L., I, M., E, L., MB, A., IL, N., BB, H., & C, B. (2026). Dolutegravir improves physical health-related quality of life in adults with HTLV-1 infection: A randomized controlled trial. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 108933. https://doi.org/10.1016/j.ijid.2026.108933

Chicago Style (17th ed.) Citation

L, Lins-Kusterer, Montaño-Castellón I, Luz E, Arriaga MB, Nunes IL, Herrera BB, and Brites C. "Dolutegravir Improves Physical Health-related Quality of Life in Adults with HTLV-1 Infection: A Randomized Controlled Trial." International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases 2026: 108933. https://doi.org/10.1016/j.ijid.2026.108933.

MLA (9th ed.) Citation

L, Lins-Kusterer, et al. "Dolutegravir Improves Physical Health-related Quality of Life in Adults with HTLV-1 Infection: A Randomized Controlled Trial." International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases, 2026, p. 108933, https://doi.org/10.1016/j.ijid.2026.108933.